Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Critical Reviews in Oncology/Hematology
|
November 25, 2011
Polycomb genes and cancer: time for clinical application?
Francesco Crea, Elisa Paolicchi, Victor E Marquez, et al.
Critical Reviews in Oncology/Hematology
|
December 26, 2012
Histone lysine demethylases in breast cancer
Elisa Paolicchi, Francesco Crea, William L Farrar, et al.
Oncotarget
|
February 10, 2016
Targeting hypoxic response for cancer therapy
Elisa Paolicchi, Federica Gemignani, Marija Krstic-Demonacos, et al.
Biomarkers in Medicine
|
March 28, 2012
An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw
Fabio La Ferla, Elisa Paolicchi, Francesco Crea, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
September 30, 2011
Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies
Francesco Crea, Stefania Nobili, Elisa Paolicchi, et al.
Molecular Cancer Therapeutics
|
May 25, 2012
Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells
Amir Avan, Francesco Crea, Elisa Paolicchi, et al.
Oncology Letters
|
November 2, 2013
A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma
Elisa Paolicchi, Paola Pacetti, Elisa Giovannetti, et al.
Oncology
|
September 1, 2016
Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients
Elisa Paolicchi, Caterina Vivaldi, Veronica De Gregorio, et al.
Investigational New Drugs
|
December 10, 2020
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
Irene Dell'Anno, Sarah A Martin, Marcella Barbarino, et al.
BMC Cancer
|
November 11, 2015
Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer
Lorenzo Fornaro, Pinuccia Faviana, Veronica De Gregorio, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Critical Reviews in Oncology/Hematology
|
November 25, 2011
Polycomb genes and cancer: time for clinical application?
Francesco Crea, Elisa Paolicchi, Victor E Marquez, et al.
Critical Reviews in Oncology/Hematology
|
December 26, 2012
Histone lysine demethylases in breast cancer
Elisa Paolicchi, Francesco Crea, William L Farrar, et al.
Oncotarget
|
February 10, 2016
Targeting hypoxic response for cancer therapy
Elisa Paolicchi, Federica Gemignani, Marija Krstic-Demonacos, et al.
Biomarkers in Medicine
|
March 28, 2012
An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw
Fabio La Ferla, Elisa Paolicchi, Francesco Crea, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
September 30, 2011
Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies
Francesco Crea, Stefania Nobili, Elisa Paolicchi, et al.
Molecular Cancer Therapeutics
|
May 25, 2012
Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells
Amir Avan, Francesco Crea, Elisa Paolicchi, et al.
Oncology Letters
|
November 2, 2013
A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma
Elisa Paolicchi, Paola Pacetti, Elisa Giovannetti, et al.
Oncology
|
September 1, 2016
Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients
Elisa Paolicchi, Caterina Vivaldi, Veronica De Gregorio, et al.
Investigational New Drugs
|
December 10, 2020
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
Irene Dell'Anno, Sarah A Martin, Marcella Barbarino, et al.
BMC Cancer
|
November 11, 2015
Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer
Lorenzo Fornaro, Pinuccia Faviana, Veronica De Gregorio, et al.
Page
of 2